|
Oct 1
|
BioVie Receives Notice of Allowance for United States Patent Application Covering Novel Liquid Formulation of Terlipressin
|
|
Aug 27
|
BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting
|
|
Aug 8
|
BioVie Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson’s Disease
|
|
Aug 6
|
BioVie Inc. Announces Reverse Stock Split
|
|
Aug 6
|
Individual investors invested in BioVie Inc. (NASDAQ:BIVI) copped the brunt of last week's US$55m market cap decline
|
|
Jun 25
|
BioVie Presents Protocol Design of Upcoming SUNRISE-PD Phase 2 Trial of Bezisterim in Patients with Early Parkinson’s Disease at ATMRD 2024
|
|
Jun 21
|
BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
|
Jun 20
|
BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Parkinson’s Disease at 2024 ATMRD Congress
|
|
Apr 29
|
BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID
|
|
Apr 25
|
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
|
|
Apr 18
|
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
|
|
Apr 12
|
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
|
Mar 12
|
Bears are Losing Control Over BioVie Inc. (BIVI), Here's Why It's a 'Buy' Now
|
|
Mar 11
|
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
|
|
Mar 6
|
BioVie Inc. Announces Closing of Public Offering
|
|
Mar 4
|
BioVie Inc. Announces Pricing of Public Offering
|
|
Feb 6
|
BioVie to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
|
Dec 29
|
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
|
|
Dec 22
|
Rail Vision and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
|
|
Dec 11
|
BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|